PMV Pharmaceuticals

quit fire layoff workforce reduction exit

PMV lays off 30% to fund ph. 2 trial of solid tumor drug

PMV Pharma is laying off 30% of its staff as the precision oncology biotech prioritizes pushing its lead solid tumor candidate toward a phase 2 trial this year.

James Waldron Jan 19, 2024 8:29am

PMV Pharma nabs $70M for tumor suppressor programs

Aug 3, 2020 10:45pm

Chutes & Ladders—AZ research exec jumps to startup Goldfinch

Dec 8, 2017 8:20am

Cancer startup PMV Pharma gains impressive $74M B round

Feb 22, 2017 8:21am